Search - tctmd.com

Displaying 461 - 480 of 944

Sort: Relevancy | Date

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Conference News ESC 2020

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

Yael L. Maxwell

September 02, 2020

News Daily News

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

L.A. McKeown

August 31, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

L.A. McKeown

August 04, 2020

News Conference News SCCT 2020

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

Yael L. Maxwell

July 28, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

News Conference News SCCT 2020

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

Yael L. Maxwell

July 22, 2020

News Conference News SCCT 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Yael L. Maxwell

July 20, 2020

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Most Stable Angina Patients Not Taking First-line Meds

Shelley Wood

June 18, 2020

News Daily News

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

L.A. McKeown

June 17, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

Advertisement

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs

TCTMD’s Top 10 Most Popular Stories for August 2020

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Biggest Barriers to Cardiac CT? Old Myths, Fair Payment, and De-adoption

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Most Stable Angina Patients Not Taking First-line Meds

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content